Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 40Rectal Neoplasms 21Colorectal Neoplasms 20Colonic Neoplasms 19Glioblastoma 13Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 11Gliosarcoma 11Central Nervous System Neoplasms 11Esophageal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Adenocarcinoma Of Esophagus 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Ovarian Neoplasms 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Melanoma 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Salivary Gland Neoplasms 4Nasopharyngeal Carcinoma 4Lymphoma 4Fallopian Tube Neoplasms 4

Interventions

Gemcitabine 87Cisplatin 66Cystectomy 38pembrolizumab 34Docetaxel 25Nivolumab 24durvalumab 21Paclitaxel 19Magnetic Resonance Spectroscopy 18Radiotherapy 17Mitomycin 17Carboplatin 16atezolizumab 15Doxorubicin 14Cystoscopy 14BCG Vaccine 13Surveys and Questionnaires 12Standard of Care 12avelumab 11Sunitinib 10tremelimumab 9Transurethral Resection of Bladder 9Ipilimumab 9Filgrastim 9Blood Specimen Collection 9Specimen Handling 8Neoadjuvant Therapy 8Methotrexate 8Methods 8Early Intervention, Educational 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Urinary Bladder Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT03789682 2025-04-16

CD155 in Bladder Cancer

Fudan University

Completed
151 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00006105 2013-09-05

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

University of Chicago

Phase 2 Completed
37 enrolled
Genitourinary

Urinary Bladder Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡